dota peptides peptides - GLP-1peptides is used in the treatment and diagnosis of certain types of cancer The Crucial Role of DOTA Peptides in Modern Medical Imaging and Therapy

DOTAconjugation DOTA peptides represent a significant advancement in medical diagnostics and therapeutics, particularly in the field of oncology. These sophisticated molecules combine the targeting capabilities of peptides with the strong metal-chelating properties of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA). This powerful synergy allows for the precise delivery of radioactive isotopes to specific cells or tissues, revolutionizing how certain diseases are visualized and treated.

The fundamental utility of DOTA lies in its ability to form highly stable complexes with a variety of metal ions, including radiometalsDetermination of peptide content of DOTA-peptides by metal .... When conjugated to a peptide, this chelating agent acts as a scaffold, effectively anchoring the radioactive element. This DOTA conjugation process is critical for ensuring that the radiolabeled peptide remains intact and stable once administered, delivering its therapeutic or diagnostic payload accurately.DOTAis an organic compound and commonly used as a complexing agent, which has been widely used as contrast agent for cancer treatments. The development of DOTA-peptide conjugates has paved the way for enhanced imaging techniques and targeted radionuclide therapiesConjugation of DOTA-like chelating agents to peptides ....

One of the most prominent applications of DOTA peptides is in the imaging and treatment of neuroendocrine tumors (NETs). For instance, DOTATATE acetate is a well-established DOTA-conjugated peptide that targets somatostatin receptors, which are often overexpressed on NET cells. When labeled with radionuclides such as Gallium-68 ((68)Ga) or Lutetium-177 ((177)Lu), these radiopharmaceuticals enable highly sensitive Positron Emission Tomography (PET) imaging to detect and stage NETs. Furthermore, the therapeutic potential of radionuclides like (177)Lu allows for targeted radiation therapy, known as Peptide Receptor Radionuclide Therapy (PRRT)Solid‐Phase Synthesis of DOTA–Peptides - Chemistry Europe. DOTA-TATE therapy, for example, utilizes (177)Lu-DOTATATE to directly deliver radiation to tumor cells expressing somatostatin receptors, offering a personalized treatment approachPractical Aspects of labeling DTPA- and DOTA- Peptides with.

Beyond NETs, DOTA peptides are also employed in the diagnosis and treatment of other cancers.Preparation of 68Ga-labelled DOTA-peptides using a ... Radiolabeled DOTA peptides are used routinely in adults to image neuroendocrine tumors and have shown significant potential for imaging and treating neuroblastoma. The ability to visualize and quantify receptor expression, as seen with DOTA-TATE, provides crucial insights into tumor biology, receptor status, and potential treatment responses.DOTA Peptideis used as a complexing agent in medical applicationsas contrast agents and cancer treatments for example in positron emission tomography. Another example is DOTA-JR11, a somatostatin receptor 2 (SSTR2) antagonist that can be labeled with (68)Ga for paired imaging in NET research.Practical Aspects of labeling DTPA- and DOTA- Peptides with

The scientific community has invested considerable effort in understanding and optimizing the synthesis and labeling of these complex molecules. Research into the synthesis and chelation chemistry of DOTA-peptide conjugates has led to the development of robust methods for creating these compounds. Solid-phase synthesis techniques, such as those described for DOTA preparation and its linkage to peptides directly on a solid-phase support, allow for the versatile and controlled introduction of DOTA into any sequence of a peptide. This methodology is crucial for the efficient production of high-quality DOTA-peptides.

Ensuring the quality and efficacy of these agents is paramount. Studies have focused on practical aspects of labeling, including optimizing labeling procedures of DOTA-peptides and developing methods to quantify content and purity of DOTA-peptide.DOTATATE acetate | DOTA-Conjugated Peptide The kinetics of labeling are particularly important, with research indicating that kinetics of labelling of DOTA-peptides were optimal at pH 4-4.5. Furthermore, techniques have been developed to monitor the quality of final labeled DTPA- and DOTA-conjugated peptides, ensuring their stability, specific activity, incorporation yield, and radiochemical purity.

The development of DOTA-peptide radiopharmaceuticals has greatly expanded the field of molecular imaging.Conjugation of DOTA-like chelating agents to peptides ... DOTA-peptides for PET imaging can be labelled with 68 Ga with high specific activities, enabling their widespread clinical application. Ga-DOTA-peptides are a promising PET radiotracers used in the detection of different tumour types due to their ability to bind specifically to receptors.DOTA-TOC(DOTA-[Tyr3]-octreotide) is an octreotide-based peptide carrying a tyrosine substitution at position 3 and a DOTA chelator for radiolabeling. This advancement offers a more precise and less invasive way to diagnose and monitor disease progression.

In summary, DOTA peptides are a cornerstone of modern nuclear medicine, serving as versatile tools for both diagnostic imaging and targeted radionuclide therapy. Their ability to chelate medically relevant radionuclides and target specific biological pathways has transformed patient care, offering improved diagnostic accuracy and more effective treatment options for a range of serious conditions. The ongoing research in DOTA conjugation, synthesis, and radiolabeling promises even further advancements in this critical area of medical science.